Blog

Articles, guides, and regulatory updates from our community.

AllClinical ApplicationsLongevityPeptide BasicsProvider ResourcesResearch & ScienceSafety & RegulationWeight Management
503A503BAnti-AgingBPC-157BremelanotideCJC-1295CircadianComplianceCompoundingCopper PeptideDSIPEpitalonEvidence ReviewFDAFDA ApprovedGHK-CuGIGLP-1Getting StartedGrowth HormoneGut HealthHealingHumaninIBSImmune SupportImmunologyIpamorelinKPVLarazotideLongevityMOTS-cMelanocortinMitochondriaNAD+ObesityPT-141Patient EducationPeptide BasicsPharmacyProvider GuideQualityRecoveryRegulationResearchSafetySemaglutideSexual HealthSide EffectsSkin HealthSleepTesamorelinThymosin Alpha-1TirzepatideWeight Management
Showing 1 article tagged PT-141Clear filters
Jan 10, 20269 min read
Clinical Applications

PT-141: The First FDA-Approved Peptide for Sexual Health

How bremelanotide (PT-141) works through melanocortin receptors to address hypoactive sexual desire disorder — mechanism, clinical data, and practical prescribing considerations.

PT-141BremelanotideSexual Health+2

By Peptide Association Editorial Team